entertainment -WSS

entertainment

author：Wikipedia 2025-09-30 22:41:59 - browse：82

Sarepta - Cambridge -AP — A logo sign outside of the headquarters of Sarepta Therapeutics in Cambridge, Mass. Kristoffer Tripplaar/Sipa via AP

Reviewers at the Food and Drug Administration were leaning toward rejecting a closely watched gene therapy for Duchenne muscular dystrophy made by Sarepta Therapeutics, prompting a top official to intervene earlier this year, according to three people with direct knowledge of the agency deliberations.

Inside the FDA office that oversees gene therapies, some staff had reached a non-binding conclusion that Sarepta’s gene therapy should be rejected, the individuals said, speaking on condition of anonymity. Peter Marks, a top FDA official and vocal advocate for faster gene therapy approvals, stepped in and directed staff to schedule a public hearing on the therapy on May 12.

Sarepta announced the scheduling of the public hearing last month, but the internal deliberations that led to it have not been previously reported.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： How faith leaders like me can help address America's obesity epidemic

WSS

Resistance to cancer drugs: A new genetic explanation

'Essentially witchcraft:' A former naturopath takes on the field

Teladoc has a new CEO, but challenges remain the same

Resistance to cancer drugs: A new genetic explanation

How dance can help health care workers heal from trauma

Statins may not be needed by millions of people, study suggests

knowledge

entertainment

hotspot

The high cost of giving birth even with insurance

Deposition: Sackler embraced plan to conceal OxyContin’s strength

Alkermes shareholders re

Researchers separate signal from noise in heart wearable data

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Cigna wins case to block Amy Bricker's move to CVS

After affirmative action ruling, medical educators look to 'holistic review'

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

After affirmative action ruling, medical educators look to 'holistic review'

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

hotspot

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

Report captures long Covid’s disabling effects and policy challenges

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

ALS patient reclaims some autonomy thanks to wearable 'robot'

How faith leaders like me can help address America's obesity epidemic

The kidney, in all its complexity, is captured in a new atlas

hotspot

focus

hotspot

focus